Invention Grant
- Patent Title: Ophthalmic formulation and methods of use
-
Application No.: US17371303Application Date: 2021-07-09
-
Publication No.: US11433096B2Publication Date: 2022-09-06
- Inventor: Abdelhamid Muhammad AlQallawi , Sherif Abdelhamid AlQallawi
- Applicant: Abdelhamid Muhammad AlQallawi , Sherif Abdelhamid AlQallawi
- Applicant Address: EG Alexandria; EG Alexandria
- Assignee: Abdelhamid Muhammad AlQallawi,Sherif Abdelhamid AlQallawi
- Current Assignee: Abdelhamid Muhammad AlQallawi,Sherif Abdelhamid AlQallawi
- Current Assignee Address: EG Alexandria; EG Alexandria
- Agency: Amin Talati Wasserman LLP
- Agent J. Peter Paredes
- Main IPC: A61K33/30
- IPC: A61K33/30 ; A61P27/06 ; A61P27/04 ; A61P27/12 ; A61K9/00 ; A61K45/06
Abstract:
Provided herein are methods and compositions for an eye drop and medication. Accordingly, the eye drop and medication have the potential for the provision of and pioneering non-surgical treatment of eye conditions.
Public/Granted literature
- US20220008459A1 OPHTHALMIC FORMULATION AND METHODS OF USE Public/Granted day:2022-01-13
Information query
